Xenon Pharmaceuticals Inc.
USD60.13
+0.39 (+0.65%)
CEO
Andrea DiFabio
IPO Date
2014-11-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$59.36
Prev. Close
$59.74
Day Low
$59.36
Day High
$60.16
52W Low
$30.00
52W High
$63.95
Market Cap
$4.75B
Volume
1.69M
| -13.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -19.7% | -18.9% | 0.01 | 23.65 | -16.9 |
| 31 Dec 2022 | FY | 100.0% | -1328.9% | -17.4% | -16.6% | 0.01 | 26.44 | -19.0 |
| 31 Dec 2021 | FY | 100.0% | -427.8% | -14.3% | -13.8% | 0.02 | 39.03 | -17.3 |
| 31 Dec 2020 | FY | 100.0% | -89.7% | -16.8% | -15.2% | 0.02 | 12.30 | -18.4 |
| 31 Dec 2019 | FY | 100.0% | -609.1% | -45.2% | -28.2% | 0.18 | 3.34 | -8.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -33.4% | -28.2% | 0.15 | 29.48 | -3.6 |
| 31 Dec 2017 | FY | -8122.8% | -9872.7% | -85.4% | -66.6% | 0.19 | 10.98 | -1.7 |
| 31 Dec 2016 | FY | 38.2% | -1275.5% | -36.0% | -34.1% | 0.00 | 18.68 | -5.2 |
| -8.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -16.2% | -15.0% | 0.01 | 12.52 | -8.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -13.4% | -12.6% | 0.01 | 15.14 | -7.3 |
| 31 Mar 2025 | Q1 | 100.0% | -867.3% | -9.2% | -8.8% | 0.01 | 17.66 | -10.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -8.7% | -8.2% | 0.01 | 17.85 | -11.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -7.9% | -7.5% | 0.01 | 22.21 | -12.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -6.9% | -6.6% | 0.01 | 23.27 | -12.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -5.4% | -5.2% | 0.01 | 31.82 | -17.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -4.8% | -4.6% | 0.01 | 23.65 | -18.0 |